Atlas Trials

Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study

Clinical trial NCT01888614 · WITHDRAWN

Trial details

NCT number
NCT01888614
Sponsor
University Hospitals Cleveland Medical Center
Status
WITHDRAWN
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2013-06-01
Primary completion
2016-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.